Evidence for in vivo usage of CD46, i.e., infection of CD150-/nectin-4- cells, was not obtained during these studies even though there are enormous numbers of CD46-positive cells in close proximity to MV-infected centers. This evidence concerns the gene SLAMF1 and infection.